NCT05697861Enrolling by invitationPhase 2/3
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Long-Term Follow-Up of Subjects Treated With NTLA-2001
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
This is a follow-up study of subjects who received NTLA-2001 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.
- Status (registry)
- Enrolling by invitation
- Phase (registry)
- Phase 2/3
- Study type
- Observational
- Enrollment
- 72 (estimated)
- First submitted
- 13 Jan 2023
- Start date
- 10 Jul 2023
- Primary completion date
- Mar 2038
- Lead sponsor
- Intellia Therapeutics
- Diseases
- Amyloidosis
- NCT number
- NCT05697861
- EU CT number
- 2023-507385-11-00
- EudraCT number
- 2022-003405-30
What you commit to
- Study type: Observational · Phase 2/3
- Planned participants: 72
- From 10 Jul 2023 to the primary completion date, Mar 2038
- 4 sites in 4 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None
Who the study is looking for
- A subject has completed or discontinued from an Intellia-sponsored clinical study in which a complete or partial dose of NTLA-2001 was received.
- A subject has provided informed consent for the LTFU study.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Assistance Publique Hopitaux De Paris Coordinator of this site? Confirm its status | Le Kremlin-Bicetre | France | Recruiting |
| - Coordinator of this site? Confirm its status | London | United Kingdom | Unknown status |
| - Coordinator of this site? Confirm its status | Auckland | New Zealand | Unknown status |
| Region Vaesterbotten Coordinator of this site? Confirm its status | Umea | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.